WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 |
PATENTSCOPE
Search International and National Patent Collections
World Intellectual Property Organization
Search
Browse
Translate
Options
News
Login
Help
1. (WO2006046080) PEGYLATED LIPOSOMAL DOXORUBICIN IN COMBINATION WITH ECTEINESCIDIN 743
PCT Biblio. Data
Description
Claims
National Phase
Notices
Drawings
Documents
Latest bibliographic data on file with the International Bureau   
Pub. No.:    WO/2006/046080    International Application No.:    PCT/GB2005/050189
Publication Date: 04.05.2006 International Filing Date: 26.10.2005
IPC:
A61K 47/48 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
48
the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
Applicants: PHARMA MAR S.A., SOCIEDAD UNIPERSONAL [ES/ES]; Poligono Industrial La Mina, Avda. de los Reyes, 1 Colmenar Viejo, E-28770 Madrid (ES) (For All Designated States Except US).
ORTHO BIOTECH PRODUCTS L.P. [US/US]; 700 US Highway 202, Raritan, New Jersey 08869 (US) (For All Designated States Except US).
GILLES, Erard [FR/US]; (US) (For US Only).
STERNAS, Lars-Axel [SE/US]; (US) (For US Only).
TRIFAN, Ovid [RO/US]; (US) (For US Only).
VAN DE VELDE, Helgi [BE/BE]; (BE) (For US Only).
TEITELBAUM, April [US/US]; (US) (For US Only).
RUFFLES, Graham Keith [GB/GB]; (GB) (SD only)
Inventors: GILLES, Erard; (US).
STERNAS, Lars-Axel; (US).
TRIFAN, Ovid; (US).
VAN DE VELDE, Helgi; (BE).
TEITELBAUM, April; (US)
Agent: MARKS & CLERK; 66-68 Hills Road, Cambridge, Cambridgeshire CB2 1LA (GB)
Priority Data:
60/622,163 26.10.2004 US
Title (EN) PEGYLATED LIPOSOMAL DOXORUBICIN IN COMBINATION WITH ECTEINESCIDIN 743
(FR) TRAITEMENTS ANTICANCEREUX
Abstract: front page image
(EN)A method of treating the human body for cancer comprises administering an effective therapeutic amount of a Pegylated Liposomal form of the anthracycline Doxorubicin ('PLD'), in combination with an effective therapeutic amount of ET-743.
(FR)L'invention concerne une méthode de traitement du corps humain dirigée contre le cancer. Cette méthode consiste à administrer une quantité thérapeutique efficace d'une forme liposomale pégylée de l'anthracycline doxorubicine (PLD), combinée à une quantité thérapeutique efficace de ET-743
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Org. (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)